EZH2 Is Increased in Paediatric T-Cell Acute Lymphoblastic Leukemia and Is a Suitable Molecular Target in Combination Treatment Approaches

Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-015-0191-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pre-T Cell Receptor Signaling Drives Leukemogenesis and Is a Therapeutic Target in T Cell Acute Lymphoblastic Leukemia

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

DNMT3A Mutation Is Associated With Increased Age and Adverse Outcome in Adult T-Acute Lymphoblastic Leukemia

Haematologica
Hematology
2019English

Targeting IRAK1 in T-Cell Acute Lymphoblastic Leukemia

Oncotarget
Oncology
2015English

The Molecular Basis of Lmo2-Induced T-Cell Acute Lymphoblastic Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2010English

Leukemia-Initiating Cell Activity Requires Calcineurin in T-Cell Acute Lymphoblastic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Solanine Induced Apoptosis and Increased Chemosensitivity to Adriamycin in T-Cell Acute Lymphoblastic Leukemia Cells

Oncology Letters
Cancer ResearchOncology
2018English

BCL-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia

Cancer Research
Cancer ResearchOncology
2019English

Overcoming Steroid Resistance in T Cell Acute Lymphoblastic Leukemia

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2016English

CRLF2 Over-Expression Is a Poor Prognostic Marker in Children With High Risk T-Cell Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy